Application of CD226 extracellular domain protein in inhibition of tumor cell proliferation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- IMMUNOPHARMACEUTIC INST OF HEFEI RUIDA CO LTD
- Publication Date
- 2015-05-27
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention mainly belongs to the field of tumor immunology, and mainly relates to the preparation and application of a protein involved in inhibiting tumor cell growth. Specifically, the present invention relates to the use of CD226 extracellular segment protein to inhibit the proliferation of tumor cells. Background technique
[0002] Natural killer cells (Natural Killer, NK cells) play an extremely important role in innate immunity, mainly including killing tumor cells, killing virus-infected cells, killing intracellular parasites and killing fungi. NK cells mainly function directly in two ways; one is to produce inhibitory effects on target cells by secreting cytokines. The second is to activate NK cells to kill target cells through the recognition between NK cell surface receptors and ligands.
[0003] NK cells function mainly through various activating receptors and inhibitory receptors on the surface of NK cells. CD226 molecule is an activa...